Ticlopidine hydrochloride is a platelet aggregation inhibitor capable of inducing apoptosis in various cancer cell lines by antagonizing the P2Y12 receptor, which is responsible for initiating the signal transduction that causes platelets to aggregate.
Chen WH, Yin HL, Chang YY et al. Kaohsiung J Med Sci. 13:589-97 (1997). Ma L, Elliott SN, Cirino G et al. Proc Natl Acad Sci U S A. 98:6470-5 (2001).
See how others have used Ticlopidine Hydrochloride (CAS 53885-35-1). Click on the entry to view the PubMed entry .
PMID: # 25939592 Kaneko, M.|Minematsu, T.|Yoshida, M.|Nishijima, Y.|Noguchi, H.|Ohta, Y.|Nakagami, G.|Mori, T.|Sanada, H.| et al. 2015. Wound Repair Regen. 23: 657-63.
PMID: # 25422175 Wang, W. et al. 2015. Chirality. 27: 170-6.